封面
市场调查报告书
商品编码
1808931

橘皮组织治疗市场,按治疗类型、性别、年龄层、最终用户、国家和地区分类 - 2025 年至 2032 年全球行业分析、市场规模、市场份额及预测

Cellulite Treatment Market, By Treatment Type, By Gender, By Age Group, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年橘皮组织治疗市场规模价值 24.0233 亿美元,2025 年至 2032 年的复合年增长率为 10.11%。

随着美学意识的提升(尤其是女性),以及对非侵入性美容手术的需求不断增长,橘皮组织治疗市场正在稳步增长。久坐的生活方式、荷尔蒙变化和老化等因素导致橘皮组织高发,尤其是在女性群体中。雷射疗法和射频等非侵入性疗法因其安全性和极短的恢復期而广受欢迎。随着消费者寻求价格实惠的替代方案,家用解决方案和外用产品的需求也呈现激增之势。橘皮组织治疗市场正在快速成长,这得益于技术创新、更广泛的美学意识以及对非侵入性个人化解决方案日益增长的需求。然而,品牌和诊所必须应对关键挑战,尤其是在信任、价格承受能力和应对复杂的监管方面,才能将消费者的兴趣转化为永续的成长。

橘皮组织治疗市场-市场动态

非侵入性美容手术的需求不断增长

橘皮组织治疗市场的主要驱动力之一是对非侵入性和微创美容手术的需求不断增长。消费者越来越寻求效果显着、不适感、恢復时间或风险最小的治疗方法。根据美国整形外科医师协会的数据,过去五年中,非侵入性美容手术增加了20%以上,凸显人们明显转向更安全的门诊治疗。射频、雷射治疗和冷冻溶脂等技术因其非手术性质和相对较快的疗效而被广泛用于减少橘皮组织。根据美国国立卫生研究院 (NIH) 的最新调查,全球橘皮组织治疗增加了3.4%,其中包括2023年由整形外科医生实施的3,490万例外科和非手术美容手术。全球实施的外科手术超过1,580万例,非手术手术超过1,910万例。随着塑身和紧緻肌肤趋势的持续增长,尤其是在25-45岁的女性群体中,全球对此类解决方案的需求也在增长,从而推动了整体市场的成长。

橘皮组织治疗市场-关键见解

根据我们的研究分析师的分析,预测期内(2025-2032 年)全球市场预计年复合成长率约为 10.11%

根据治疗类型细分,预计非侵入式治疗将在 2024 年占据最大市场份额

根据年龄段细分,18-30 岁是 2024 年的主要年龄段

根据最终用途细分,美容诊所/医疗水疗中心是 2024 年的主要最终用途

按地区划分,北美是 2024 年的主要收入来源

橘皮组织治疗市场-細項分析:

全球橘皮组织治疗市场根据治疗类型、性别、年龄层、最终用户和地区进行细分。

根据治疗类型,市场分为三类:非侵入性、微创性和局部治疗。在这三种治疗类型中,非侵入性疗法在橘皮组织治疗市场中占据主导地位。这主要归功于其无痛、恢復时间短、风险低于手术治疗的优势。射频、雷射和超音波等疗法深受患者和医生的青睐。随着对快速、无需恢復期的临床解决方案的需求日益增长,非侵入性疗法已成为已开发市场和新兴市场中最常用的疗法。

根据最终用户,市场可分为四类:医院、皮肤科诊所、美容诊所/医疗水疗中心以及家庭使用。在这四类最终用户中,美容诊所/医疗水疗中心在橘皮组织治疗市场占据主导地位。这些机构专注于美容手术,并配备了先进的非侵入式技术,特别适合减少橘皮组织。它们提供舒适专业的环境和个人化的治疗方案,吸引了大量寻求快速有效治疗的患者。与医院相比,它们价格实惠,且专注于美容护理,使其成为消费者最青睐的选择。

橘皮组织治疗市场—地理洞察

北美引领橘皮组织治疗市场,这得益于消费者在美容手术上的高支出、先进的医学美容基础设施以及人们对非侵入性治疗的广泛认知。由于对塑身和抗衰老服务的需求不断增长,美国占据了主要份额。欧洲紧追在后,德国、法国和英国等国家对美容技术的采用程度很高。同时,亚太地区正在迅速崛起,这得益于中国、韩国和印度等国家日益增强的美容意识、不断增长的可支配收入以及皮肤科服务覆盖面的扩大。拉丁美洲、中东和非洲地区成长温和,但由于城市化进程加快以及人们对美容外观日益增长的兴趣,该地区蕴藏着尚未开发的潜力。

橘皮组织治疗市场-竞争格局:

橘皮组织治疗市场较为分散,多家知名公司和新创企业在非侵入式、微创式和局部治疗领域竞争。橘皮组织影响高达 90% 的女性,美国每年用于治疗的资金超过 10 亿美元。该领域的主要公司包括 Soliton, Inc.、Shockwave Medical, Inc.、辉瑞公司、Sesen Bio, Inc. 和波士顿科学公司。 Soliton 宣布,在其减少橘皮组织的概念验证临床试验(「POC 试验」)获得积极资料后,决定推进一项针对橘皮组织的关键性试验。这些公司正在投资射频、雷射系统和注射解决方案等先进技术,以提高治疗效果和患者满意度。为了加强市场影响力,各公司之间进行策略合作、产品发布和区域扩张十分常见。艾尔建的注射疗法 QWO(R) 和豪洛捷的 SculpSure(R) 雷射平台是备受瞩目的创新产品,正在获得市场关注。随着对非手术美容解决方案的需求不断增长,设备製造商和美容服务提供者之间的竞争日益激烈。

最新动态:

2024年11月,Tiger Aesthetics Medical, LLC宣布收购Revelle Aesthetics, Inc.,后者是突破性消脂设备Aveli的开发商,该设备已获得FDA批准。此次收购将扩大Tiger Aesthetics在快速发展的再生身体美学领域的影响力,并透过先进的下半身年轻化解决方案补充其产品组合。

2021年5月,艾伯维(AbbVie)旗下公司艾尔建美学(Allergan Aesthetics)宣布以约5.5亿美元收购Soliton Inc.,以扩大其橘皮组织治疗产品组合。 Soliton的RESONIC快速声波脉衝设备已获得FDA批准,可用于非侵入性橘皮组织治疗,临床试验中患者满意度高达92.9%。此次收购是艾尔建现有的CoolSculpting Elite系列产品的补充。此举巩固了艾尔建在美学塑身市场的地位。

目录

第一章:消脂治疗市场概述

  • 研究范围
  • 市场估计年限

第二章:执行摘要

  • 市场片段
    • 橘皮组织治疗市场片段(依治疗类型)
    • 橘皮组织治疗市场按性别分類的片段
    • 橘皮组织治疗市场按年龄细分
    • 橘皮组织治疗市场片段(按最终用户)
    • 各国橘皮组织治疗市场概况
    • 橘皮组织治疗市场(按地区)
  • 竞争洞察

第三章:消脂治疗的主要市场趋势

  • 橘皮组织治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 橘皮组织治疗市场的限制
    • 市场限制的影响分析
  • 橘皮组织治疗市场机会
  • 橘皮组织治疗市场未来趋势

第四章:消脂治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章:消脂市场:地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章:消脂治疗市场格局

  • 2024年橘皮组织治疗市占分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章:橘皮组织治疗市场-依治疗类型

  • 概述
    • 按治疗类型分類的细分市场份额分析
    • 非侵入性
    • 微创
    • 外用

第 8 章:消脂治疗市场 - 依性别

  • 概述
    • 按性别分類的细分市场占有率分析
    • 女性
    • 男性

第九章:消脂治疗市场-依年龄组

  • 概述
    • 按年龄组别分類的细分份额分析
    • 18-30岁
    • 31-45岁
    • 46-60岁
    • 60岁以上

第 10 章:橘皮组织治疗市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 皮肤科诊所
    • 美容诊所/医疗水疗中心
    • 家庭使用

第 11 章:消脂治疗市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美消脂治疗主要製造商
    • 北美市场规模及预测(按国家/地区)
    • 北美市场规模和预测,按治疗类型
    • 北美市场规模及预测(依性别)
    • 北美市场规模及预测(按年龄层)
    • 北美市场规模和预测(按最终用户)
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲消脂治疗主要製造商
    • 欧洲市场规模及预测(按国家/地区)
    • 欧洲市场规模及预测(按治疗类型)
    • 欧洲市场规模及预测(依性别)
    • 欧洲市场规模及预测(依年龄层)
    • 欧洲市场规模和预测(按最终用户)
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区消脂治疗主要製造商
    • 亚太地区市场规模及预测(依国家)
    • 亚太地区市场规模及预测(依治疗类型)
    • 亚太地区市场规模及预测(依性别)
    • 亚太地区市场规模及预测(依年龄层)
    • 亚太地区市场规模及预测(依最终用户)
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲(LATAM)
    • 概述
    • 拉丁美洲的消脂治疗关键製造商
    • 拉丁美洲市场规模及预测(按国家/地区)
    • 拉丁美洲市场规模及预测(按治疗类型)
    • 拉丁美洲市场规模及预测(依性别)
    • 拉丁美洲市场规模及预测(按年龄层)
    • 拉丁美洲市场规模及预测(按最终用户)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲(MEA)
    • 概述
    • 中东和非洲的消脂治疗主要製造商
    • MEA 市场规模及预测(依国家/地区)
    • MEA 市场规模及预测(依治疗类型)
    • MEA 市场规模及预测(依性别)
    • MEA 市场规模及预测(依年龄层)
    • MEA 市场规模和预测(按最终用户)
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 12 章:关键供应商分析-消脂治疗产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • AbbVie Inc. (Allergan Aesthetics)
    • Lumenis Ltd.
    • Candela Medical
    • Solta Medical
    • Cynosure LLC
    • BTL Aesthetics
    • Cutera Inc.
    • Merz Pharmaceuticals
    • Endo International plc
    • Venus Concept Inc.
    • Others

第 13 章:360 度分析师视角

第 14 章:附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5556

Cellulite Treatment Market size was valued at US$ 2,402.33 Million in 2024, expanding at a CAGR of 10.11% from 2025 to 2032.

The cellulite treatment market is experiencing steady growth due to rising aesthetic awareness, especially among women, and the increasing demand for non-invasive cosmetic procedures. Factors such as a sedentary lifestyle, hormonal changes, and aging contribute to the high prevalence of cellulite, particularly in the female population. Non-invasive treatments like laser therapy and radiofrequency are highly popular for their safety and minimal downtime. The market is also seeing a surge in at-home solutions and topical products as consumers seek affordable alternatives. The cellulite treatment market is growing fast, powered by technological innovation, broader aesthetic awareness, and rising demand for non-invasive, personalized solutions. However, brands and clinics must address critical challenges, especially around trust, affordability, and navigating regulatory complexity, to convert interest into sustainable growth.

Cellulite Treatment Market- Market Dynamics

Rising Demand for Non-Invasive Aesthetic Procedures

One of the primary drivers of the cellulite treatment market is the increasing demand for non-invasive and minimally invasive cosmetic procedures. Consumers increasingly seek treatments that offer visible results with minimal discomfort, recovery time, or risk. According to the American Society of Plastic Surgeons, non-invasive cosmetic procedures increased by over 20% in the last five years, highlighting a clear shift toward safer, outpatient treatments. Technologies like radiofrequency, laser therapy, and cryolipolysis are widely adopted for cellulite reduction due to their non-surgical nature and relatively quick results. As per the National Institute of Health (NIH), the latest survey reported a global increase of 3.4%, including 34.9 million surgical and nonsurgical aesthetic procedures performed by plastic surgeons in 2023. More than 15.8 million surgical procedures and more than 19.1 million nonsurgical procedures were performed worldwide. As body contouring and skin-tightening trends continue to grow, particularly among women aged 25-45, the demand for such solutions globally is rising, fueling overall market growth.

Cellulite Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.11% over the forecast period (2025-2032)

Based on Treatment Type segmentation, Non-Invasive was predicted to show maximum market share in the year 2024

Based on age group segmentation, 18-30 years was the leading age group in 2024

Based on end use segmentation, Aesthetic Clinics/Medical Spas was the leading end use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Cellulite Treatment Market- Segmentation Analysis:

The Global Cellulite Treatment Market is segmented on the basis of Treatment Type, Gender, Age Group, End User, and Region.

The market is divided into three categories based on Treatment Type: Non-Invasive, Minimally Invasive, and Topical. Among the three treatment types, the Non-Invasive segment dominates the cellulite treatment market. This is largely due to its painless procedures, minimal recovery time, and lower risk compared to surgical options. Treatments like radiofrequency, laser therapy, and ultrasound are widely preferred by patients and practitioners alike. The increasing demand for quick, clinic-based solutions without downtime has made non-invasive methods the most adopted category in both developed and emerging markets.

The market is divided into four categories based on end user: Hospitals, Dermatology Clinics, Aesthetic Clinics/Medical Spas, and Home Use. Among the four end-user segments, Aesthetic Clinics/Medical Spas dominate the cellulite treatment market. These facilities specialize in cosmetic procedures and are equipped with advanced, non-invasive technologies preferred for cellulite reduction. They offer a comfortable, professional environment with personalized treatment plans, attracting a large number of patients seeking quick and effective results. Their affordability compared to hospitals and focus on beauty care make them the most popular choice among consumers.

Cellulite Treatment Market- Geographical Insights

North America leads the cellulite treatment market, driven by high consumer spending on cosmetic procedures, advanced medical aesthetics infrastructure, and widespread awareness of non-invasive treatments. The United States holds a major share due to the growing demand for body contouring and anti-aging services. Europe follows closely, with countries like Germany, France, and the UK showing strong adoption of aesthetic technologies. Meanwhile, the Asia-Pacific region is emerging rapidly, fueled by increasing beauty consciousness, rising disposable incomes, and expanding access to dermatology services in countries like China, South Korea, and India. Latin America and the Middle East & Africa show moderate growth but hold untapped potential due to growing urbanization and rising interest in appearance enhancement.

Cellulite Treatment Market- Competitive Landscape:

The cellulite treatment market is moderately fragmented, with several established companies and emerging players competing across non-invasive, minimally invasive, and topical segments. Cellulite affects up to 90% of women and over a billion dollars per year is spent on treatment in the US. Key companies in this space include Soliton, Inc., Shockwave Medical, Inc., Pfizer Inc., Sesen Bio, Inc., and Boston Scientific Corporation. Soliton has announced its decision to move forward with a pivotal trial in cellulite after positive data from its proof of concept clinical trial for the reduction of cellulite (the "POC Trial") confirmed. These companies are investing in advanced technologies like radiofrequency, laser systems, and injectable solutions to enhance treatment efficacy and patient satisfaction. Strategic collaborations, product launches, and regional expansions are common as companies aim to strengthen market presence. Allergan's injectable treatment, QWO(R), and Hologic's SculpSure(R) laser platform are notable innovations gaining market traction. With growing demand for non-surgical cosmetic solutions, competition is intensifying among device manufacturers and aesthetic service providers.

Recent Developments:

In November 2024, Tiger Aesthetics Medical, LLC announced the acquisition of Revelle Aesthetics, Inc., the developer of Aveli, a breakthrough FDA-cleared cellulite reduction device. This acquisition expands Tiger Aesthetics' presence in the fast-growing field of regenerative body aesthetics, complementing its portfolio with advanced solutions for lower body rejuvenation.

In May 2021, Allergan Aesthetics, an AbbVie company, announced the acquisition of Soliton Inc. for approximately $550 million to expand its cellulite treatment portfolio. Soliton's RESONIC Rapid Acoustic Pulse device, FDA-cleared for non-invasive cellulite treatment, showed 92.9% patient satisfaction in clinical trials. The acquisition complements Allergan's existing CoolSculpting Elite offerings. This move strengthens Allergan's position in the aesthetic body contouring market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as following:

GLOBAL CELLULITE TREATMENT MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc. (Allergan Aesthetics)
  • Lumenis Ltd.
  • Candela Medical
  • Solta Medical
  • Cynosure LLC
  • BTL Aesthetics
  • Cutera Inc.
  • Merz Pharmaceuticals
  • Endo International plc
  • Venus Concept Inc.
  • Others

GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Non-Invasive
  • Minimally Invasive
  • Topical

GLOBAL CELLULITE TREATMENT MARKET, BY GENDER- MARKET ANALYSIS, 2019 - 2032

  • Female
  • Male

GLOBAL CELLULITE TREATMENT MARKET, BY AGE GROUP - MARKET ANALYSIS, 2019 - 2032

  • 18-30 years
  • 31-45 years
  • 46-60 years
  • Above 60 years

GLOBAL CELLULITE TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Dermatology Clinics
  • Aesthetic Clinics/Medical Spas
  • Home Use

GLOBAL CELLULITE TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cellulite Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cellulite Treatment Market Snippet by Treatment Type
    • 2.1.2. Cellulite Treatment Market Snippet by Gender
    • 2.1.3. Cellulite Treatment Market Snippet by Age Group
    • 2.1.4. Cellulite Treatment Market Snippet by End User
    • 2.1.5. Cellulite Treatment Market Snippet by Country
    • 2.1.6. Cellulite Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Cellulite Treatment Key Market Trends

  • 3.1. Cellulite Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cellulite Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cellulite Treatment Market Opportunities
  • 3.4. Cellulite Treatment Market Future Trends

4. Cellulite Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cellulite Treatment Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cellulite Treatment Market Landscape

  • 6.1. Cellulite Treatment Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cellulite Treatment Market - By Treatment Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Treatment Type, 2024 & 2032 (%)
    • 7.1.2. Non-Invasive
    • 7.1.3. Minimally Invasive
    • 7.1.4. Topical

8. Cellulite Treatment Market - By Gender

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Gender, 2024 & 2032 (%)
    • 8.1.2. Female
    • 8.1.3. Male

9. Cellulite Treatment Market - By Age Group

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Age Group, 2024 & 2032 (%)
    • 9.1.2. 18-30 years
    • 9.1.3. 31-45 years
    • 9.1.4. 46-60 years
    • 9.1.5. Above 60 years

10. Cellulite Treatment Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Dermatology Clinics
    • 10.1.4. Aesthetic Clinics/Medical Spas
    • 10.1.5. Home Use

11. Cellulite Treatment Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cellulite Treatment Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cellulite Treatment Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cellulite Treatment Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Cellulite Treatment Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Cellulite Treatment Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Gender, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cellulite Treatment Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. AbbVie Inc. (Allergan Aesthetics)
    • 12.2.2. Lumenis Ltd.
    • 12.2.3. Candela Medical
    • 12.2.4. Solta Medical
    • 12.2.5. Cynosure LLC
    • 12.2.6. BTL Aesthetics
    • 12.2.7. Cutera Inc.
    • 12.2.8. Merz Pharmaceuticals
    • 12.2.9. Endo International plc
    • 12.2.10. Venus Concept Inc.
    • 12.2.11. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us